AIIC
AJU IB Investment Company Portfolio holdings
AUM
$91.9M
This Quarter Return
+60.2%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$264M
AUM Growth
–
Cap. Flow
+$264M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
99.97%
Holding
11
New
11
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Atea Pharmaceuticals
AVIR
|
$85.6M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$63.8M |
| 3 |
Seer Inc
SEER
|
$59.9M |
| 4 |
Kymera Therapeutics
KYMR
|
$43.7M |
| 5 |
Sutro Biopharma
STRO
|
$3.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Atea Pharmaceuticals
AVIR
$267M
| $85.6M | 32.4% | +2,049,331 | New | +$85.6M |
|
|
2
Apellis Pharmaceuticals
APLS
$3.48B
| $63.8M | 24.13% | +1,114,962 | New | +$63.8M |
|
|
3
Seer Inc
SEER
$115M
| $59.9M | 22.65% | +1,066,375 | New | +$59.9M |
|
|
4
Kymera Therapeutics
KYMR
$2.95B
| $43.7M | 16.52% | +704,059 | New | +$43.7M |
|
|
5
Sutro Biopharma
STRO
$72.7M
| $3.8M | 1.44% | +175,000 | New | +$3.8M |
|
6
Clearside Biomedical
CLSD
$28.9M
| $2.17M | 0.82% | +793,555 | New | +$2.17M |
|
7
RAPT Therapeutics
RAPT
$188M
| $2.14M | 0.81% | +108,503 | New | +$2.14M |
|
|
MTEM
8
DELISTED
Molecular Templates, Inc.
MTEM
| $1.92M | 0.73% | +204,809 | New | +$1.92M |
|
9
Kezar Life Sciences
KZR
$28.9M
| $673K | 0.25% | +128,916 | New | +$673K |
|
|
RNTX
10
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $538K | 0.2% | +517,558 | New | +$538K |
|
|
BLCM
11
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $91K | 0.03% | +25,651 | New | +$91K |
|